NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):13-21

Copyright © 2009 EDIZIONI MINERVA MEDICA

lingua: Inglese

Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract

Rindi G., Capella C. *, Solcia E. **

From the Pathology Services University of Brescia, *Insubria, and **Pavia, Italy

A ­revised cli­nic­o­path­o­log­i­cal clas­sifi­ca­tion of neu­ro­en­do­crine ­tumors of the gas­troen­te­rop­an­creat­ic ­tract has ­been recent­ly devel­oped ­under the aus­pic­es of the World Health Organization (WHO) accord­ing to advanc­es in the ­field of ­tumor biol­o­gy. Here the clas­sifi­ca­tion is brief­ly out­lined and dis­cussed togeth­er ­with the guide­lines for a cor­rect ­approach to the his­to­path­o­log­i­cal diag­no­sis of neu­ro­en­do­crine ­tumors and the inter­pre­ta­tion of the clas­sifi­ca­tion ­schemes cov­er­ing clin­i­cal (hyper­func­tion­al syn­dromes includ­ed), path­o­log­i­cal and bio­log­i­cal pat­terns, ­with spe­cial empha­sis on ­tumor prog­no­sis.